H. Giezek

发表

Extended-release niacin/laropiprant lowers serum phosphorus concentrations in patients with type 2 diabetes.

W. Hanlon, A. Bostom, A. Maclean, 2011, Journal of clinical lipidology.

Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.

J. Mckenney, H. Bays, A. Tershakovec, 2012, Metabolic syndrome and related disorders.

Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial

Stanley B. Cohen, T. Schnitzer, K. Saag, 2009, The Journal of Rheumatology.

Bone Loss : A 12-Month Randomized , Placebo-Controlled Clinical Trial Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced

Stanley B. Cohen, T. Schnitzer, K. Saag, 2009 .

Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood

T. Hartert, T. Reiss, M. Everard, 2016, Pediatric pulmonology.

Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention

M. Shivaprakash, R. Raz, F. Köckerling, 2006, Journal of Gastrointestinal Surgery.

Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy

J. Quinn, R. Weinstein, M. Shivaprakash, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections.

M. Shivaprakash, M. Dinubile, F. Branicki, 2005, International journal of surgery.

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment.

Keunchil Park, M. Aapro, J. von Pawel, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Long‐Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial

C. Lines, K. Connor, S. Aurora, 2011, Headache.

Effects of odanacatib on bone-turnover markers in osteoporotic postmenopausal women: a post hoc analysis of the LOFT study

L. Duong, S. Stoch, R. Massaad, 2022, Osteoporosis International.

Comparison of aprepitant combination regimen with 4-day ondansetron + 4-day dexamethasone for prevention of acute and delayed nausea/vomiting after cisplatin chemotherapy

M. Aapro, H. Schmoll, C. Chan, 2005 .

Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers

C. Meyerhoff, M. Benedetti, H. Giezek, 2001, Fundamental & clinical pharmacology.

Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey

M. Krempf, J. Tomassini, P. Brudi, 2015, Lipids in Health and Disease.

The Efficacy of Montelukast during the Allergy Season in Pediatric Patients with Persistent Asthma and Seasonal Aeroallergen Sensitivity

N. Papadopoulos, P. Polos, S. Smugar, 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

Efficacy and safety of extended‐release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia

J. Paolini, R. Češka, D. Maccubbin, 2010, International journal of clinical practice.

Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma

P. Zinzani, K. Ardeshna, F. Morschhauser, 2019, Leukemia & lymphoma.

Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.

J. Quinn, R. Weinstein, M. Shivaprakash, 2007, Diagnostic microbiology and infectious disease.

Outcomes of patients with the third or higher relapsed classical Hodgkin lymphoma: results from the German Hodgkin Study Group.

A. Engert, A. Balakumaran, P. Bröckelmann, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis

E. Orwoll, N. Binkley, R. Chapurlat, 2020, Osteoporosis International.

Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind study

M. Shivaprakash, M. Hupli, J. Grifka, 2005, Current medical research and opinion.

Effect of odanacatib on bone density and estimated bone strength in postmenopausal women: a CT-based sub-study of the phase 3 long-term odanacatib fracture trial (LOFT)

H. Genant, T. Keaveny, K. Engelke, 2016 .

Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia.

H. Bays, P. Brudi, M. Farnier, 2013, The American journal of cardiology.

Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5‐Year Data From the Phase 3 Long‐Term Odanacatib Fracture Trial (LOFT) and its Extension

L. Duong, R. Recker, D. Dempster, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.